Novartis acquires all remaining rights to GSK’s Ofatumumab
To develop treatments for MS and other autoimmune indications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlaxoSmithKline
MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot
Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret
GSK agrees UK deal for meningitis shot after Novartis stand-off
Britain will become the first country in the world to have a nationwide vaccination programme for the potentially deadly childhood…
Novartis completes series of transactions with GlaxoSmithKline
Acquires certain oncology products and pipeline compounds from GSK
Fortune announces list of 2015 ‘World’s Most Admired Companies’
Fortune magazine has announced its list of 2015 'World’s Most Admired Companies.' The companies on the world’s most admired list…
Frost & Sullivan releases drug launch and Phase III trial watch list for top therapeutic areas
Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015
CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis
It involves acquisition of GSK's portfolio of oncology products by Novartis for $16 billion